Takayuki Takeda

35PUBLICATIONS
49CO-AUTHORS
Molecular targetsPredictive and prognostic markersRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Nov 04, 2024
YAP Regulates HER3 Signaling-Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant Cancers.

Yuki Katayama, Tadaaki Yamada, Keiko Tanimura

|Oct 28, 2023
First-Line Chemoimmunotherapy versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung Cancer with ≤49% Programmed Death-Ligand 1 Expression: A Real-World Multicenter Retrospective Study.

Keiko Tanimura, Takayuki Takeda, Nobutaka Kataoka

|Sep 09, 2023
Predictive Value of Modified Glasgow Prognostic Score and Persistent Inflammation among Patients with Non-Small Cell Lung Cancer Treated with Durvalumab Consolidation after Chemoradiotherapy: A Multicenter Retrospective Study.

Keiko Tanimura, Takayuki Takeda, Akihiro Yoshimura

|Aug 24, 2023
Endobronchial metastasis of hepatocellular carcinoma treated with Lenvatinib: A case report.

Shota Takei, Akihiro Yoshimura, Chie Yamamoto

|Mar 17, 2023
Pseudoprogression during induction treatment with nivolumab plus ipilimumab combined with chemotherapy for metastatic lung adenocarcinoma: A case report.

Yusuke Kunimatsu, Yukari Kano, Rei Tsutsumi

|Mar 11, 2023
Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study.

Takayuki Takeda, Tadaaki Yamada, Yusuke Kunimatsu

Pageof 6

Frequent Collaborators

15 joint publications

Tadaaki Yamada

9 joint publications

Koichi Takayama

7 joint publications

Akihiro Yoshimura

7 joint publications

Keiko Tanimura